1. Home
  2. FLR vs BIO Comparison

FLR vs BIO Comparison

Compare FLR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluor Corporation

FLR

Fluor Corporation

HOLD

Current Price

$46.04

Market Cap

7.3B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$293.62

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLR
BIO
Founded
1912
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
8.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FLR
BIO
Price
$46.04
$293.62
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$49.57
$358.50
AVG Volume (30 Days)
2.6M
233.6K
Earning Date
02-17-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
1235.20
N/A
EPS
20.04
N/A
Revenue
$15,587,000,000.00
$2,557,500,000.00
Revenue This Year
N/A
$1.50
Revenue Next Year
$5.20
$2.23
P/E Ratio
$2.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.20
$211.43
52 Week High
$57.50
$368.65

Technical Indicators

Market Signals
Indicator
FLR
BIO
Relative Strength Index (RSI) 59.70 34.96
Support Level $45.22 $287.46
Resistance Level $47.37 $302.59
Average True Range (ATR) 1.42 8.96
MACD 0.24 -2.48
Stochastic Oscillator 71.29 15.02

Price Performance

Historical Comparison
FLR
BIO

About FLR Fluor Corporation

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: